Agency for Toxic Substances and Disease Registry (ATSDR) utilizes chemical-specific minimal risk levels (MRLs) to assist in evaluating public health risks asso ciated with exposure to hazardous substances. The MRLs are derived based on the data compiled from current worldwide literature searches and presented in ATSDR's toxicological profiles. These documents profile not only individual chemicals, but also groups of chemically related compounds and chemical mix tures. ATSDR took several approaches when devel oping MRLs for chemical mixtures. In some instances, toxicity equivalency factors were used to estimate the toxicity of the whole mixture; in other instances, the most toxic chemical was assumed to drive the health assessment for the whole mixture. Another approach was to treat the mixture as one entity and develop a health guidance value for the whole mixture. In yet another approach, each chemical of the mixture was evaluated separately and several health guidance val ues were developed. In the future, ATSDR will evalu ate priority chemical mixtures found at hazardous waste sites. A weight-of-evidence approach, physiolog ically based pharmacokinetic modeling and bench mark dose modeling, and quantitative structure-ac tivity relationships will have an impact on the develop ment of MRLs and the assessment of chemical mixtures.
Agency for Toxic Substances and Disease Registry (ATSDR) utilizes chemical-specific minimal risk levels (MRLs) to assist in evaluating public health risks asso ciated with exposure to hazardous substances. The MRLs are derived based on the data compiled from current worldwide literature searches and presented in ATSDR's toxicological profiles. These documents profile not only individual chemicals, but also groups of chemically related compounds and chemical mix tures. ATSDR took several approaches when devel oping MRLs for chemical mixtures. In some instances, toxicity equivalency factors were used to estimate the toxicity of the whole mixture; in other instances, the most toxic chemical was assumed to drive the health assessment for the whole mixture. Another approach was to treat the mixture as one entity and develop a health guidance value for the whole mixture. In yet another approach, each chemical of the mixture was evaluated separately and several health guidance val ues were developed. In the future, ATSDR will evalu ate priority chemical mixtures found at hazardous waste sites. A weight-of-evidence approach, physiolog ically based pharmacokinetic modeling and bench mark dose modeling, and quantitative structure-ac tivity relationships will have an impact on the develop ment of MRLs and the assessment of chemical mixtures. © 1997 Academic Press CHEMICAL MIXTURES-OVERVIEW A growing number of chemicals are introduced into the marketplace on a weekly basis. Of the approxi mately 7 million total chemicals, 70,000 are in current use with more than 1,000 added each year worldwide (Newill, 1989) . Until recently, research efforts have been focused primarily on the toxicology of individual chemicals. In turn, risk assessment activities have been largely concerned with individual chemical expo sures, disregarding the complexities of multiple chemi cal exposures. The dilemma of predicting the health consequences of multiple chemical exposures is not new. The problem has been studied for more than 60 years, but the challenges presented by multiple chemi cal exposures remain unmet without a clear framework nor a fundamental methodology for predicting health risks to such exposures.
Although data are frequently not adequate to assess the toxic effects of individual chemicals, even less data may be available on the toxicity of chemical mixtures. For example, with the exception of epidemiological studies, most of the available toxicological data are ob tained from laboratory studies, predominantly on indi vidual chemicals. Most of these studies involve high doses to assure detection of any potential adverse re sponses. However, populations near hazardous waste sites are rarely exposed to individual chemicals and except for acute emergency situations, they are not ex posed to high doses. Usually, exposures are to mixtures of chemicals at low doses from multiple sources and through multiple routes. The composition of such mix tures may vary with time, and human exposure levels may not be quantifiable.
The behavior of chemicals in mixtures may differ greatly from that observed for individual chemicals. Interactions of the mixture components may alter the toxicity and carcinogenicity through mechanisms such as potentiation or inhibition. Such interactions are pos tulated to result from chemically mediated alterations in a variety of biological processes such as absorption, distribution, metabolism, and excretion, which influ ence the internal dose ofa chemical. These complexities open a wide variety of research areas to chemical mix tures research including pharmacokinetics, mechanis tic studies, the identification of biomarkers, and devel opment of qualitative and quantitative health assess ment methods. Because toxicity data are generally not available on human health effects from exposure to specific chemical mixtures, assessment may rely on predictive estimates of risk. Of particular concern for chemical interactions is the use of extrapolation, from in vitro to in vivo, from high dose to low dose, and from animal to human.
Section 104 of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) as amended by Section 110 of the Superfund Amend ments and Reauthorization Act (SARA) established the requirement for ATSDR to develop methods to deter mine the health effects of chemical mixtures found at hazardous waste sites. From its inception, the agency has been concerned about the health effects of exposure to individual chemicals. Thus, individual chemicals identified at toxic waste sites are listed in priority order based on their frequency of occurrence at hazardous waste sites, their toxicity, and the potential for expo sure (ATSDR, 1996a) ;from this priority list, ATSDR's toxicological profiles for these chemicals are developed.
PUBLIC HEALTH GUIDANCE VALUES
CURRENT PRACTICE ATSDR utilizes chemical-specific minimal risk levels (MRLs) to assist in evaluating public health risks asso ciated with exposure to hazardous substances. By definition, "MRLs are estimates of daily human expo sure to a chemical that are likely to be without an appreciable risk of adverse noncancer health effects over a specified duration of exposure." The MRLs are derived based on the data compiled from current world wide literature searches and presented in ATSDR's tox icological profiles. The methodology for deriving MRLs has been described elsewhere (ATSDR, 1996b; Pohl and Abadin, 1995) . Briefly, the MRL is usually based on the highest no-observed-adverse-effect level (NOAEL) or lowest-observed-adverse-effect level (LOAEL) for the most sensitive end point.
Uncertainty factors (UFs) are applied to account for intrahuman variation, interspecies extrapolation, and LOAEL to NOAEL extrapolation. Modifying factors (MFs) may be applied to reflect additional concerns not covered by the UFs.
Since their establishment, the toxicological profiles have described not only individual chemicals (for which MRLs were originally designed), but also groups of chemically related compounds and chemical mixtures. Based on available data, ATSDR dealt with these mix tures on a case-by-case basis as described in the follow ing approaches. As summarized in Table 1 , ATSDR used these four approaches:
1. Selected the most toxic chemical from the mixture and provided a health guidance based on the MRL for this chemical. Then used toxicity equivalents (TEQs) to estimate toxicity of the whole mixture.
2. Treated the mixture as one entity and developed a health guidance for the whole mixture. (ATSDR, 1997) . The acute oral MRL of 70 pg/kg/day was based on the NOAEL of 0.005 pg/kg/ day TCDD in mice. Decreased immunocompetence was reported at 0.01 pg/kg/day TCDD administered once by gavage in oil vehicle (Burleson et al., 1996) . A UF of 30 (3 for animal to human extrapolation and 10 for human variability) and an MF of 0.7 (to adjust for ga vage oil route of exposure) were used for MRL calcula tion. The intermediate-duration oral MRL of 20 pg/kg/ day was based on a NOAEL of 0.0007 pg/kg/day TCDD for decreased thymus weight in guinea pigs exposed in their feed for 90 days (DeCaprio et al., 1986) . Also from this study, a supporting NOAEL of the same value was identified for liver toxicity. The liver effects reported at higher levels were hepatocellular inclusions and hy pertriglyceridemia. A UF of 30 was used for MRL calcu 1ation (3 for animal to human extrapolation and 10 for human variability). The chronic oral MRL of 1 pg/kg/ day TCDD was based on a LOAEL for mild learning and behavioral impairment in the offspring of monkeys exposed to 0.00012 pg/kg/day TCDD in their feed (Schantz et al., 1992) . AUF of90 was used in the calcu lation (3 for use of a minimal LOAEL, 3 for animal to human extrapolation, and 10 for human variability).
Chlorinated dibenzofurans (CDFs).
Dibenzofuran is an organic compound containing two benzene rings fused to a central furan ring. Based on the number and position of chlorine substituents, there are 135 conge ners in the CDFs group (ATSDR, 1994) . Oral MRLs were derived for 2,3,4,7,8-pentaCDF, the most toxic congener, in the database presented in the Toxicologi cal Profile for CDFs (ATSDR, 1994) . The acute oral MRL of 1000 pg/kg/day for 2,3,4,7,8-pentaCDF was based on a LOAEL for mild thymic lymphoid hypopla sia identified in guinea pigs following a single gavage dose in corn oil (Moore et al., 1979) . A UF of 1000 (10 for use of a LOAEL, 10 for animal to human extrapola tion, and 10 for human variability) and MF of 3 (for lack of neurological studies in animals) were used in the calculation. The intermediate duration MRL of 30 pg/kg/day was based on a LOAEL for hepatic effects in rats exposed for 13 weeks to 2,3,4,7 ,8-pentaCDF in feed (Pluess et al., 1988; Poiger et al., 1989) . The observed effects included increased serum bilirubin and de creased serum triglycerides. A UF of 1000 (10 for use of a LOAEL, 10 for animal to human extrapolation, and 10 for human variability) and MF of 3 (for lack of neurological studies in animals) were used in the calculation.
CDDs and CDFs are structurally and toxicologically related groups of chemicals that usually occur in the environment together. CDDs and CDFs are believed to act through the same Ah receptor-mediated mecha nism of toxicity that has been described in detail in several publications (ATSDR, 1994 (ATSDR, , 1997 Birnbaum, 1994) . To assess the risk associated with exposure to mixtures of CDDs and CDFs, the Environmental Pro tection Agency (EPA) (1989a) developed toxicity equiv alency factors (TEFs) that compare the relative toxicity ofindividual CDD and CDF congeners to that ofTCDD, the most toxic and extensively studied chemical from the halogenated aromatic hydrocarbons group. The TEF for TCDD is 1; all others are < 1, thus indicating the lower potency of other dioxin-like compounds. TEQ is defined as the product of the concentration of an individual dioxin-like compound in a complex environ mental mixture and the corresponding TCDD toxicity equivalency factor for that compound. The total TEQ is the sum of the TEQs for each of the congeners in a given mixture. Assuming additivity of the toxic re sponse, generated TEQs can be used to estimate the toxicity of an environmental mixture containing a known distribution of CDDs or CDFs relative to that ofTCDD. For existing TEFs of selected dioxin-like com pounds, see the relevant toxicological profiles (ATSDR, 1994 (ATSDR, , 1997 . The system was also endorsed by the World Health Organization (Ahlborg et al., 1994) .
Some uncertainties and limitations are still associ ated with the TEFs approach. Some ofthe assumptions for using this approach include a well-defined group of chemicals, a broad database of information, consistency across end points, additivity of the effects, and a com mon mechanism of action (EPA, 1989a) .
The limitations associated with the use ofTEQs must be considered in developing health guidance values. TEQs are derived using TEFs that are constants deter mined from experimental studies for each congener. Although considered constants, these factors exhibit some variability with dose, duration of exposure, and end point. As defined, TEQs are assumed to be additive. In actual mixtures of dioxin and dioxin-like com pounds, competitive inhibition may occur at sufficiently high doses. However, there is a lack of knowledge re garding actual direction of possible interactions in any specific mixture of dioxin-like compounds. According to EPA guidelines for risk assessment of complex mix tures, potency-weighted additivity is assumed for mix tures in the absence of information to the contrary (EPA, 1987) . Because of the existing data gaps, ATSDR is adopting the additivity approach as well.
Assuming that the conditions set for the TEF system are valid, we could anticipate that the health guidance values derived for dioxin-like chemicals are similar. That is, the estimates of daily human exposure to spe cific congeners of dioxin-like chemicals that are likely to be without risks of adverse non cancer health effects (MRLs) should also be similar when adjusting for the relative potency in the toxicity of each specific conge ner. When the respective proposed MRLs for TCDD and 2,3,4,7,8-pentaCDF were expressed in TEQs and compared with each other, there was a good correlation between intermediate-duration oral MRLs, but not for acute-duration oral MRLs (Pohl and Holler, 1995 The acute oral MRL was derived from a study in rats exposed to an unspecified mixture of PBBs in lecithin liposomes by gavage for 10 days (Allen-Rowlands et al., 1981) . An MRL of 0.01 mglkg/day was based on a NOAEL of 1 mglkg/day. A UF of 100 (10 for animal to human extrapolation and 10 for human variability) was used in the calculation. Decreased serum levels of thyroid T4 hormone were observed at ~3 mglkg/day. Decreased serum T4 is considered adverse because of unequivocal evidence from numerous studies that the thyroid is a target of PBBs showing a spectrum of ef fects, including decreases in serum T3 and T4 hormone, thyroid enlargement, effects on the follicular cells, and accumulation of colloid droplets (ATSDR, 1995a) . Al though the mixture of PBBs used in the Allen-Row lands et al. (1981) study was unspecified, it likely con tained isomers in which bromine was present in the meta and para positions, as these isomers are known to result in thymic effects and a wasting syndrome.
Polychlorinated biphenyls (PCBs).
PCBs are a group of compounds in which 1 to 10 chlorine atoms are attached to the biphenyl molecule (ATSDR, 1995b) . Depending on the number and position of chlorines, there are 209 chlorobiphenyl congeners. In the United States, PCBs were manufactured under the trade name Aroclor. The number that follows the trade name (e.g., Aroclor 1242) indicates that it is a chlorinated biphenyl mixture (12) with a certain percent of chlo rine content (42%).
A chronic oral MRL was derived for PCBs based on the toxicity of Aroclor 1254. The MRL of 0.02 f.1glkgl day was based on a LOAEL for immunological effects in monkeys exposed to Aroclor 1254 in feed for 23 months (Tryphonas et al., 1989 (Tryphonas et al., , 1991a . Immunological test ing of exposed monkeys revealed decreased IgG and IgM levels in response to sheep red blood cells. A UF of 300 (10 for use of a LOAEL, 3 for animal to human extrapolation, and 10 for human variability) was used in the calculation.
As described, ATSDR's MRL for PCBs was based on a commercial mixture. The decision for MRL derivation was influenced by availability of toxicological data. Most laboratory studies were performed with defined commercial mixtures. However, people are environ mentally exposed to PCB mixtures of different conge neric composition than commercial mixtures. This is due to the differential partitioning and transformation of the individual congeners in the environment (ATSDR, 1995b) . To estimate the health risk associated with environmental mixtures of PCBs, the TEFs method, described in this paper under related haloge nated hydrocarbons, was also proposed for PCBs (Ahlb org et al., 1994; EPA, 1991; Safe, 1990 Safe, , 1994 . Again, toxicity of individual PCB congeners was estimated rel ative to TCDD. All PCB congeners were given TEFs < 1, thus reflecting their lower toxic potency. In addi tion to the limitations already described, the major drawback of this method is that it is designed only for dioxin-like compounds. Dioxin-like compounds are those containing chlorine or bromine on molecules that are shaped similarly to TCDD, produce similar toxic effects, and act through the same Ah receptor-related mechanism of action (Schierow, 1995) . Some coplanar PCBs match this description; only about 13 of the total 209 PCB congeners were actually assigned a TEF value. Other PCB congeners may act through different mechanisms of toxicity. Some PCBs-induced effects, e.g., carcinogenic and behavioral, are probably not me diated by the Ah receptor (Ahlborg et al., 1992; Safe, 1990) . Further, it is known that, in relation to dioxins, specific PCBs appear to display an antagonistic or syn ergistic and therefore a nonadditive effect. The TEF approach is potentially useful for evaluating risk asso ciated with exposure to dioxin-like compounds, because it could enable assessments that would account for spe cific congener composition at particular hazardous waste sites. Because of the knowledge gaps for toxico logical data on individual congeners and other limita tions stated previously, the method needs further de velopment. Meanwhile, ATSDR's MRL for a specific commercial mixture (Aroclor 1254) is a screening method of choice.
From the group of petroleum products, the following mixtures were considered.
Fuel oils. Fuel oils are complex mixtures of ali phatic and aromatic hydrocarbons that are refined from crude petroleum; their composition varies with the re finery stream from which they are blended (ATSDR, 1995c) . The aliphatic alkanes (paraffins) and cycloal kanes (naphthenes) are hydrogen saturated and com pose about 80-90% of the fuel oils. Aromatics (e.g., benzene) and ole fins (e.g., styrene and indene) consti tute 10-20% and 1%, respectively, ofthe fuel oils. Fuel oil No. 1 (kerosene) is a light distillate that consists mainly of hydrocarbons in the C 9 -C 16 range, whereas fuel oil No.2 is heavier with hydrocarbons in the C ll C 20 range. These fuel oils are used as residential heat ing oils and as diesel fuels.
There are human and animal data on the toxicologi cal effects of fuel oils. However, the database is diverse in that the studies reported on differing fuel oils or mixtures that are not completely alike. Therefore, when deriving MRLs, the diversity was acknowledged. The MRL derived for one type of fuel product does not· necessarily apply to another.
An acute inhalation MRL of 0.02 mg/m 3 for diesel fuel (fuel oil No.2) was based on a LOAEL of 65 mg/m 3 for neurobehavioral effects (mild transient ataxia and central nervous system depression) ob served in mice exposed only through the nose in a study by Kainz and White (1984) . For MRL derivation, the LOAEL was adjusted for intermittent exposure and divided by a UF of 1000 (10 for extrapolation from LOAEL to NOAEL, 10 for extrapolation from animals to humans, and 10 for human variability).
An intermediate inhalation MRL of 0.01 mg/m 3 for fuel oil No.1 (kerosene) was derived based on a LOAEL of 58 mg/m 3 for decreased blood glucose levels reported in mice exposed for 14 weeks (Starek and Vojtisek, 1986) . For MRL derivation, the LOAEL was adjusted for intermittent exposure and divided by a UF of 1000 (10 for extrapolation from LOAEL to NOAEL, 10 for extrapolation from animals to humans, and 10 for hu man variability).
Jet fuels JP-4 and JP-7. Aviation fuels are complex mixtures of hydrocarbon compounds (paraffins, cyclo paraffins, naphthenes, aromatics, and olefins) (ATSDR, 1995d). They also contain additives (e.g., antioxidants, icing inhibitors, metal deactivators) determined by the specific use of the respective fuel. Typical detailed com position of jet fuels was described elsewhere (ATSDR, 1995d) .
Similar to the approach used for the fuel oils, ATSDR treated the exposure to a jet fuel as exposure to one entity. Exposure to jet fuel components, exhaust, or combustion products was not considered.
An MRL of 9 mg/m 3 was derived for intermediate duration inhalation exposure to JP-4. The MRL was derived from a LOAEL of 500 mg/m 3 for increased hepatic toxicity in mice reported in a continuous expo sure 90-day study (Air Force, 1984) . The JP-4 concen tration is based on the total hydrocarbon present in the vapors after the original mixture was heated to 50°C. The hepatic changes included vacuolization of cytoplasm of hepatocytes, mainly in the centrilobular region, and increased incidence of fatty degenerative changes. The LOAEL was adjusted to a human equiv alent dose and divided by a UF of 300 (10 for use of a LOAEL, 3 for interspecies extrapolation, and 10 for human variability).
An MRL of 0.3 mg/m 3 was derived for chronic-dura tion inhalation exposure to JP-7. The MRL was based on a LOAEL of 150 mg/m 3 that caused hepatic toxicity (inflammation) in female rats (Air Force, 1991) . No such effects were observed in males. The dose was ad justed to a human equivalent and to continuous expo sure and divided by a UF of 300 (10 for use of a LOAEL, 3 for interspecies extrapolation, and 10 for human vari ability).
In the Third Approach, Each Chemical from the Mixture Was Treated Separately and Several Health Guidance Values Were Developed Polycyclic aromatic hydrocarbons (PARs).
PARs are a group of chemicals that are formed during the incomplete burning of some organic substances (e.g., coal, oil, gas, garbage) (ATSDR 1995e). More than 100 different PARs are known. Some occur naturally and others are synthetic. Environmentally, people are usu ally exposed to a mixture of PARs. Although informa tion exists on complex mixtures that contain PARs (e.g., crude oils, coal tars, complex petroleum products), it is difficult to establish the toxicity of individual com ponents ofthe mixture because ofthe potential interac tions that could take place and the presence of other toxic chemicals in these mixtures. ATSDR's Toxicologi cal Profile for PARs described the toxicity of 17 individ ual PARs for which toxicity data were available. These PARs were treated separately during the health risk assessment, because some of the PARs differ with re gard to toxicological effects or environmental fate. The reason for disparity is based on electron density associ ated with the molecule. From that arose the classifica tion of PARs as alternate (i.e., those having equally distributed electron density) and nonalternate (i.e., those having uneven distribution of electron density from one portion of the molecule to another). As exam ples, benzo[a]pyrene, benz [a] anthracene, chrysene, and dibenz [a,h] anthracene belong in the alternate group, whereas fluoranthene, benzo[k]fluoranthene, benzoU]fluoranthene, and indeno [1,2,3-c,d ]pyrene be long in the nonalternate group. The toxicological sig nificance ofthis classification is that alternate and non alternate PARs seem to behave differently, for in stance, with regard to how they are metabolized to ultimate carcinogens. For more details, see ATSDR (1995e) .
From the 17 PARs described in the profile, MRLs were derived only for acenaphthene, anthracene, fluo ranthene, and fluorene. The carcinogenicity classifica tion assigned these chemicals to group D (not classifi able as to human carcinogenicity) (IRIS, 1994) . The MRLs were derived as follows.
Acenaphthene. An intermediate-duration oral MRL was based on a LOAEL of 175 mglkg/day for absolute liver weight in mice treated daily by gavage for 90 days (EPA, 1989b) . Liver weight changes, accompanied by microscopic alterations (cellular hypertrophy), were noted in higher dose groups and seemed to be dose related. Relative liver weight was significantly in creased in male mice at 175 mglkg/day, and absolute and relative weights were significantly increased in fe male mice at 175 mglkg/day. The exposure level was considered a minimal LOAEL, which when divided by aUF of300 (3 for a minimum LOAEL, 10 for extrapola tion from animals to humans, and 10 for human vari ability) yielded an intermediate-duration oral MRL of 0.6 mglkg/day.
Anthracene. An MRL of 10 mglkg/day was derived for intermediate-duration oral exposure to anthracene. The MRL was based on a NOAEL of 1000 mglkg/day for liver effects reported in mice exposed by gavage for 13 weeks (EPA, 1989c) . The MRL was obtained by dividing the NOAEL value by a UF of 100 (10 for ex trapolation from animals to humans and 10 for human variability).
Fluoranthene. An intermediate-duration oral MRL of 0.4 mg/kg/day was based on a LOAEL of 125 mg/kg/ day for liver weight changes in mice treated daily by gavage for 90 days (EPA, 1988) using a UF of 300 (3 for a minimal LOAEL, 10 for extrapolation from ani mals to humans, and 10 for human variability).
Fluorene. Similarly, an intermediate-duration oral MRL of 0.4 mg/kg/day was based on a LOAEL of 125 mg/kg/day for liver weight changes in mice treated daily by gavage for 90 days (EPA, 1989d) using a UF of 300 (3 for a minimal LOAEL, 10 for extrapolation from ani mals to humans, and 10 for human variability).
In contrast, MRLs were not derived for some PARs that are probable human carcinogens (group B2) (IRIS 1994) , such as benzo [a] pyrene, benzo[b]fluoranthene, and benz [a] anthracene. For these PARs, the carcinoge nicity should drive the risk assessment. In recent years, the TEFs methodology was recommended for as sessing the risk associated with exposure to a mixture of PARs (EPA, 1993; Nisbet and LaGoy, 1992) . The toxicity of different PARs was compared with that of benzo [a] pyrene, which was assigned a TEF of 1 (ATSDR, 1995e). Carcinogenicity induced by individual PARs was the basis for TEFs designation. Similar to the TEFs system for dioxin-like chemicals, the TEFs approach for PARs required several assumptions. These included prerequisites such as a well-character ized PAR that could serve as a reference compound for all the others in the mixture, qualitatively similar toxic effects, similar end points, additivity oftoxic effect, etc. (Nisbet and LaGoy, 1992) . When we calculated the TEQ values for ATSDR's MRLs, we found that the val ues for anthracene and acenaphthene were comparable and so were the values for fluorene and fluoranthene. However, there was a threefold difference in TEQ val ues between the two groups. It is important to note that the MRLs are based on the most sensitive noncan cer end points. In contrast, TEFs for PARs are based on carcinogenicity. Therefore, the TEFs method for PARs (as currently developed) should not be used for health effects other than cancer, and derivation ofsepa rate MRLs for individual PAR compounds, as done by ATSDR, is an appropriate approach.
ATSDR Did Not Derive MRLs for Some of the Mixtures Featured in the Toxicological Profiles
These included automotive gasoline, Stoddard sol vent, hydraulic fluids, and mineral-based crankcase oil. ATSDR concluded that all these mixtures can vary in chemical components and concentrations, making it difficult to apply assessments from one scenario to an other. When considered appropriate, the most toxic chemical from the mixture could be selected and as sumed to drive the risk assessment. An example of this approach is using benzene as a marker for the environmental exposure to automotive gasoline.
FUTURE DIRECTIONS
Development of alternative risk assessment proce dures and models is a complex, data-intensive task; paucity of data is frequently the bottleneck to devel oping potential hazard-assessment methods or models of risk assessment of chemical mixtures, such as inter action prediction. In the process of reducing the uncer tainties in public health risk assessments, improving the accuracy of MRLs, and providing interim health based guidance values, ATSDR is considering the po tential impact of physiologically based pharmacoki netic modeling, benchmark dose modeling, and quanti tative structure-activity relationships on the develop ment of MRLs. ATSDR is also assessing specific chemicals and chemical mixtures using the in vitro functional screening approach. In addition, a weight of-evidence (WOE) approach (Mumtaz and Durkin, 1992) is being used to predict the toxicity of some sim ple chemical mixtures based on published literature and then compare these predictions with test results from animal toxicity studies. The WOE evaluation pro cess uses individual chemical dose/response assess ments and algorithms that incorporate various as sumptions regarding potential chemical interactions.
CONCLUSION
At this time, ATSDR has not developed a guidance policy for development of MRLs to address each type of chemical mixture. Rather, each mixture is consid ered on a case-by-case approach as seen in the exam ples given in this paper. Developing such guidance is difficult because of the nature of different mixtures, which may be similar or dissimilar, simple or complex. Because no such guidance exists and our knowledge of chemical mixtures is continuous and evolving, consis tency in the MRL process has been difficult to maintain over time. Ultimately, the criteria for evaluating the MRLs for mixtures are a balanced consideration of the science, consistent application of uncertainty factors and modifying factors, and the best combination of sci ence and judgment in the protection of public health.
